Neomorph Raises $109M in Series A Financing
Neomorph, Inc., a San Diego, CA-based biotechnology company, raised $109m in Series A financing. The company intends to use the funds to further develop its platform, advance lead programs, and expand the research team. Deerfield Management Company established Neomorph earlier this year with scientific founders Phil Chamberlain, DPhil; Eric Fischer, PhD; Benjamin Ebert, MD, PhD; and Scott Armstrong, MD, PhD. The company is building a protein degradation entity, focused on “molecular glue” degraders. Targeted protein degradation offers opportunities to develop novel therapeutics across a...
Source: finsmes.com